Related Experiment Videos
[Chemotherapy in lung carcinoma]
Therapeutische Umschau. Revue Therapeutique
|April 1, 1994
Summary
Lung cancer remains a leading cause of death, with survival rates improving despite limited systemic therapy breakthroughs for advanced lung cancer. This review covers recent advancements in treating both non-small cell and small cell lung cancer.
Area of Science:
- Oncology
- Pulmonology
- Public Health
Context:
- Lung cancer is a significant cause of mortality globally, closely linked to smoking prevalence.
- Despite ongoing research, effective systemic therapies for advanced lung cancer remain elusive.
- Long-term survival rates for lung cancer patients have shown a gradual increase over recent decades.
Purpose:
- To review recent therapeutic advancements in the management of lung cancer.
- To provide an overview of progress in treating both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
Summary:
- This review synthesizes current progress in lung cancer treatment strategies.
- It highlights developments in systemic therapy for advanced lung cancer, acknowledging the persistent challenges.
- The focus is on recent therapeutic developments for NSCLC and SCLC patients.
Impact:
- Improved understanding of current lung cancer treatment landscape.
- Informing clinicians and researchers on the latest therapeutic progress.
- Contributing to the ongoing efforts to enhance long-term survival for lung cancer patients.